Actelion Denied Judgment In Tracleer Antitrust Suit

Law360, Chicago (October 21, 2013, 8:00 PM EDT) -- A New Jersey federal judge on Monday rejected Actelion Pharmaceuticals Ltd.’s bid for a quick end to its lawsuit claiming antitrust laws don’t require it to supply its Tracleer blood pressure medicine to aid in developing generics, ruling in favor of several generic-drug makers and ordering the case to proceed to discovery.

In a brief order, U.S. District Judge Noel L. Hillman denied Actelion’s motion for judgment on the pleadings and to dismiss counterclaims filed by the defendants, which include Apotex Inc., Roxane Laboratories and Actavis...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.